iShares U.S. Pharmaceuticals ETF Rating $105.42 +0.26 (+0.25%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.72Holdings in IHE have an aggregate rating of Moderate Buy based on 358 analyst ratings issued in the past year covering 25 companies (91.8% of the portfolio).IHE Aggregate Price Target$105.42High Prediction$105.42Average Prediction$105.42Low Prediction$105.42Holdings in IHE have an aggregate price target of $105.42 and a range of $105.42 to $105.42 covering 25 companies (91.8% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.16%JNJJohnson & Johnson$278.66+1.3%4.5737 of 5 stars2.80$272.83 -2.1%25Trending NewsAnalyst ForecastAnalyst Revision21.65%LLYEli Lilly and Company$1,160.98+0.1%4.9235 of 5 stars2.83$1,292.18 11.3%30Trending NewsAnalyst Upgrade4.95%MRKMerck & Co., Inc.$152.32+0.4%4.5149 of 5 stars2.65$147.60 -3.1%23Positive NewsAnalyst Revision4.66%BMYBristol Myers Squibb$68.06+0.6%4.7223 of 5 stars2.56$66.06 -2.9%25Trending NewsAnalyst Revision4.39%RPRXRoyalty Pharma$63.88+1.2%3.7366 of 5 stars3.00$60.86 -4.7%84.29%PFEPfizer$28.82-0.7%3.8867 of 5 stars2.19$28.28 -1.9%21Trending NewsAnalyst UpgradeOptions VolumeAnalyst Revision3.99%VTRSViatris$16.94-0.9%2.5863 of 5 stars2.57$17.50 3.3%73.65%ZTSZoetis$76.34+0.2%4.9404 of 5 stars2.32$107.43 40.7%19Positive News3.34%JAZZJazz Pharmaceuticals$247.57+0.8%3.8465 of 5 stars3.00$285.44 15.3%18Insider Trade2.52%ELANElanco Animal Health$24.41-1.1%4.6498 of 5 stars2.77$29.09 19.2%13Positive News2.48%CORTCorcept Therapeutics$112.80+2.1%4.2363 of 5 stars2.50$138.17 22.5%8Insider Trade1.93%AXSMAxsome Therapeutics$208.35-0.7%4.1978 of 5 stars2.91$267.60 28.4%22Analyst ForecastInsider Trade1.91%CRNXCrinetics Pharmaceuticals$84.951.4624 of 5 stars2.24$81.00 -4.6%17News CoverageAnalyst Forecast1.26%DFTXDefinium Therapeutics$38.00-2.3%3.8579 of 5 stars3.00$63.00 65.8%201.23%LGNDLigand Pharmaceuticals$289.74+1.0%3.779 of 5 stars3.00$335.75 15.9%9Positive News1.07%LQDALiquidia$68.63-1.5%4.2764 of 5 stars2.45$98.08 42.9%11Trending News0.99%INDVIndivior$34.83-0.6%4.2343 of 5 stars2.71$45.17 29.7%7Positive News0.77%OGNOrganon & Co.$13.78+0.1%1.7514 of 5 stars1.71$11.40 -17.3%70.72%AMLXAmylyx Pharmaceuticals$33.96-1.5%2.2831 of 5 stars3.00$36.50 7.5%110.70%EWTXEdgewise Therapeutics$41.95-0.1%3.408 of 5 stars2.82$50.33 20.0%11News CoveragePositive News0.69%ELVNEnliven Therapeutics$59.65+1.1%2.8503 of 5 stars2.78$75.00 25.7%90.66%AMRXAmneal Pharmaceuticals$17.87-1.1%3.1673 of 5 stars3.13$19.00 6.3%80.61%TARSTarsus Pharmaceuticals$83.21+0.5%2.3969 of 5 stars2.78$90.50 8.8%9Positive NewsInsider Trade0.59%SUPNSupernus Pharmaceuticals$43.97-0.1%4.516 of 5 stars2.71$62.83 42.9%7Positive News0.54%NKTRNektar Therapeutics$76.37+5.0%2.5014 of 5 stars2.77$141.50 85.3%13 This page (NYSEARCA:IHE) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
